Literature DB >> 730075

Is hypergastrinaemia associated with rheumatoid arthritis?

D R Rowden, I L Taylor, J A Richter, R S Pinals, R A Levine.   

Abstract

In an attempt to confirm the reported high incidence of raised serum gastrin levels in patients with rheumatoid arthritis (RA), gastrin concentrations were estimated in 54 patients. Only three patients (6%) had basal hypergastrinaemia. The heptadecapeptide (G17) and total carboxyl-terminal immunoreactive gastrin responses to a standard protein meal were measured by specific radioimmunoassay in these three patients and in nine normogastrinaemic RA patients displaying the same age range. The three hypergastrinaemic patients showed significantly greater and more prolonged G17 and total carboxylterminal immunoreactive gastrin responses to the meal compared with the normogastrinaemic RA patients (P less than 0.02). Two of these three patients agreed to have an acid output study (pentagastrin 6 microg/kg subcutaneously) and gastric mucosal biopsies taken for histology. Both were found to be achlorhydric and to have atrophic gastritis. This study suggests that basal hypergastrinaemia in RA patients is considerably less common than previously reported and, when present, is associated with achlorhydria. In addition, the incidence of achlorhydria in rheumatoid arthritis is similar to that found in a normal age-matched population.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 730075      PMCID: PMC1412233          DOI: 10.1136/gut.19.11.1064

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  8 in total

1.  Gastrin (second of two parts).

Authors:  J H Walsh; M I Grossman
Journal:  N Engl J Med       Date:  1975-06-26       Impact factor: 91.245

2.  BASAL AND HISTALOG-STIMULATED GASTRIC SECRETION IN CONTROL SUBJECTS AND IN PATIENTS WITH PEPTIC ULCER OR GASTRIC CANCER.

Authors:  M I GROSSMAN; J B KIRSNER; I E GILLESPIE
Journal:  Gastroenterology       Date:  1963-07       Impact factor: 22.682

3.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

4.  Serum immunoreactive gastrin: specificity for rheumatoid arthritis, bimodality of distribution, and failure of effect of anti-inflammatory drugs.

Authors:  P J Rooney; D M Grennan; R D Sturrock; P M Brooks; W C Dick
Journal:  Ann Rheum Dis       Date:  1976-02       Impact factor: 19.103

5.  Hypergastrinaemia in rheumatoid arthritis: disease or iatrogenesis.

Authors:  J P Rooney; J Vince; A C Kennedy; J Webb; P Lee; W C Dick; K D Buchanan; J R Hayes; J Ardill; F O'Connor
Journal:  Br Med J       Date:  1973-06-30

6.  Effect of anti-inflammatory agents on serum gastrin concentrations.

Authors:  G Curtarelli; R Caldara; L Bierti
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

7.  Serum immunoreactive gastrin in rheumatoid arthritis. Further observations on its identity, clinical specificity, and relationship to gastric function.

Authors:  P J Rooney; A C Kennedy; G H Gray; R D Sturrock; K D Buchanan; W C Dick
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

8.  Heptadecapeptide gastrin: measurement in blood by specific radioimmunoassay.

Authors:  G J Dockray; I L Taylor
Journal:  Gastroenterology       Date:  1976-12       Impact factor: 22.682

  8 in total
  2 in total

1.  Gastrin, gastric acid secretion, and gastric microflora in patients with rheumatoid arthritis.

Authors:  K Henriksson; K Uvnäs-Moberg; C E Nord; C Johansson; R Gullberg
Journal:  Ann Rheum Dis       Date:  1986-06       Impact factor: 19.103

Review 2.  Gastrointestinal and hepatic manifestations of rheumatoid arthritis.

Authors:  Ellen C Ebert; Klaus D Hagspiel
Journal:  Dig Dis Sci       Date:  2011-01-04       Impact factor: 3.487

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.